Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
Chest|June 1, 1995
Fluoxetine hydrochloride (Prozac)-induced pulmonary diseaseR J Gonzalez-Rothi, D S Zander, P R RosJournal of Clinical Pharmacology|March 20, 1998
Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a modelG Hochhaus, H Möllmann, H Derendorf, et al.Pharmaceutical Research|May 1, 1998
Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphateS Suarez, R J Gonzalez-Rothi, H Schreier, et al.Gastrointestinal Endoscopy|May 1, 1989
Midazolam-associated alterations in cardiorespiratory function during colonoscopyR H Hartke, R J Gonzalez-Rothi, N C AbbeyExperimental Lung Research|July 1, 1991
Liposomes and pulmonary alveolar macrophages: functional and morphologic interactionsR J Gonzalez-Rothi, L Straub, J L Cacace, et al.Chest|August 1, 1996
Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroidsM A Kubiet, R J Gonzalez-Rothi, R Cottey, et al.Chest|July 1, 1987
Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusionsR J Gonzalez-Rothi, S E Hannan, C I Hood, et al.Cancer Research|November 1, 1985
Rat lung macrophage tumor cytotoxin production: impairment by chronic in vivo cigarette smoke exposureD A Flick, R J Gonzalez-Rothi, J O Harris, et al.Experimental Lung Research|January 1, 1993
Pulmonary effects of chronic exposure to liposome aerosols in miceM A Myers, D A Thomas, L Straub, et al.Pharmaceutical Research|January 1, 1995
Assessment of glucocorticoid lung targeting by ex-vivo receptor binding studies in ratsG Hochhaus, R J Gonzalez-Rothi, A Lukyanov, et al.Pageof 13